Related Experiment Video
Updated: Jul 6, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Paroxysmal nocturnal hemoglobinuria (PNH)].
Jun-ichi Nishimura1, Yuzuru Kanakura
1Department of Hematology and Oncology, Osaka University Graduate School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 11, 2008
Summary
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired stem cell disorder where PIG-A mutant cells gain a survival advantage during immune-mediated bone marrow injury. These mutant clones expand, leading to PNH manifestations like hemolysis and thrombosis.
Area of Science:
- Hematology
- Stem Cell Biology
- Genetics
Context:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder of hematopoietic stem cells.
- PNH is characterized by intravascular hemolysis, venous thrombosis, and bone marrow failure.
- PIG-A mutations in hematopoietic stem cells are typically dormant in normal marrow.
Purpose:
- To elucidate the mechanism of PIG-A mutant clone expansion in PNH.
- To understand the selective advantage of PIG-A mutant cells under specific conditions.
- To identify factors contributing to the pathogenesis of paroxysmal nocturnal hemoglobinuria.
Summary:
- Acquired PIG-A mutations in hematopoietic stem cells are present but not typically advantageous.
- Immune-mediated bone marrow injury, as seen in aplastic anemia, selects for PIG-A mutant cells due to GPI-anchored protein deficiency.
- Expansion of PIG-A mutant clones is promoted by the survival advantage conferred by the mutation and cooperating growth-enhancing events.
Impact:
- Provides insight into the clonal expansion mechanism driving PNH pathogenesis.
- Highlights the role of immune selection in the development of acquired stem cell disorders.
- Informs potential therapeutic strategies targeting PIG-A mutant clones or their survival advantage.
Related Concept Videos
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
02:20Blood Types
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...